Antagonism of proteasome inhibitor-induced heme oxygenase-1 expression by PINK1 mutation.

PTEN-induced putative kinase 1 (PINK1) is an integral protein in the mitochondrial membrane and maintains mitochondrial fidelity. Pathogenic mutations in PINK1 have been identified as a cause of early-onset autosomal recessive familial Parkinson's disease (PD). The ubiquitin proteasome pathway...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiang-Jun Sheng, Hunag-Ju Tu, Wei-Lin Chien, Kai-Hsiang Kang, Dai-Hua Lu, Horng-Huei Liou, Ming-Jen Lee, Wen-Mei Fu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0183076&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850229149087563776
author Xiang-Jun Sheng
Hunag-Ju Tu
Wei-Lin Chien
Kai-Hsiang Kang
Dai-Hua Lu
Horng-Huei Liou
Ming-Jen Lee
Wen-Mei Fu
author_facet Xiang-Jun Sheng
Hunag-Ju Tu
Wei-Lin Chien
Kai-Hsiang Kang
Dai-Hua Lu
Horng-Huei Liou
Ming-Jen Lee
Wen-Mei Fu
author_sort Xiang-Jun Sheng
collection DOAJ
description PTEN-induced putative kinase 1 (PINK1) is an integral protein in the mitochondrial membrane and maintains mitochondrial fidelity. Pathogenic mutations in PINK1 have been identified as a cause of early-onset autosomal recessive familial Parkinson's disease (PD). The ubiquitin proteasome pathway is associated with neurodegenerative diseases. In this study, we investigated whether mutations of PINK1 affects the cellular stress response following proteasome inhibition. Administration of MG132, a peptide aldehyde proteasome inhibitor, significantly increased the expression of heme oxygenase-1 (HO-1) in rat dopaminergic neurons in the substantia nigra and in the SH-SY5Y neuronal cell line. The induction of HO-1 expression by proteasome inhibition was reduced in PINK1 G309D mutant cells. MG132 increased the levels of HO-1 through the Akt, p38, and Nrf2 signaling pathways. Compared with the cells expressing WT-PINK1, the phosphorylation of Akt and p38 was lower in those cells expressing the PINK1 G309D mutant, which resulted in the inhibition of the nuclear translocation of Nrf2. Furthermore, MG132-induced neuronal death was enhanced by the PINK1 G309D mutation. In this study, we demonstrated that the G309D mutation impairs the neuroprotective function of PINK1 following proteasome inhibition, which may be related to the pathogenesis of PD.
format Article
id doaj-art-2b458dba7db445929088c22ae9f9e500
institution OA Journals
issn 1932-6203
language English
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-2b458dba7db445929088c22ae9f9e5002025-08-20T02:04:20ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01128e018307610.1371/journal.pone.0183076Antagonism of proteasome inhibitor-induced heme oxygenase-1 expression by PINK1 mutation.Xiang-Jun ShengHunag-Ju TuWei-Lin ChienKai-Hsiang KangDai-Hua LuHorng-Huei LiouMing-Jen LeeWen-Mei FuPTEN-induced putative kinase 1 (PINK1) is an integral protein in the mitochondrial membrane and maintains mitochondrial fidelity. Pathogenic mutations in PINK1 have been identified as a cause of early-onset autosomal recessive familial Parkinson's disease (PD). The ubiquitin proteasome pathway is associated with neurodegenerative diseases. In this study, we investigated whether mutations of PINK1 affects the cellular stress response following proteasome inhibition. Administration of MG132, a peptide aldehyde proteasome inhibitor, significantly increased the expression of heme oxygenase-1 (HO-1) in rat dopaminergic neurons in the substantia nigra and in the SH-SY5Y neuronal cell line. The induction of HO-1 expression by proteasome inhibition was reduced in PINK1 G309D mutant cells. MG132 increased the levels of HO-1 through the Akt, p38, and Nrf2 signaling pathways. Compared with the cells expressing WT-PINK1, the phosphorylation of Akt and p38 was lower in those cells expressing the PINK1 G309D mutant, which resulted in the inhibition of the nuclear translocation of Nrf2. Furthermore, MG132-induced neuronal death was enhanced by the PINK1 G309D mutation. In this study, we demonstrated that the G309D mutation impairs the neuroprotective function of PINK1 following proteasome inhibition, which may be related to the pathogenesis of PD.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0183076&type=printable
spellingShingle Xiang-Jun Sheng
Hunag-Ju Tu
Wei-Lin Chien
Kai-Hsiang Kang
Dai-Hua Lu
Horng-Huei Liou
Ming-Jen Lee
Wen-Mei Fu
Antagonism of proteasome inhibitor-induced heme oxygenase-1 expression by PINK1 mutation.
PLoS ONE
title Antagonism of proteasome inhibitor-induced heme oxygenase-1 expression by PINK1 mutation.
title_full Antagonism of proteasome inhibitor-induced heme oxygenase-1 expression by PINK1 mutation.
title_fullStr Antagonism of proteasome inhibitor-induced heme oxygenase-1 expression by PINK1 mutation.
title_full_unstemmed Antagonism of proteasome inhibitor-induced heme oxygenase-1 expression by PINK1 mutation.
title_short Antagonism of proteasome inhibitor-induced heme oxygenase-1 expression by PINK1 mutation.
title_sort antagonism of proteasome inhibitor induced heme oxygenase 1 expression by pink1 mutation
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0183076&type=printable
work_keys_str_mv AT xiangjunsheng antagonismofproteasomeinhibitorinducedhemeoxygenase1expressionbypink1mutation
AT hunagjutu antagonismofproteasomeinhibitorinducedhemeoxygenase1expressionbypink1mutation
AT weilinchien antagonismofproteasomeinhibitorinducedhemeoxygenase1expressionbypink1mutation
AT kaihsiangkang antagonismofproteasomeinhibitorinducedhemeoxygenase1expressionbypink1mutation
AT daihualu antagonismofproteasomeinhibitorinducedhemeoxygenase1expressionbypink1mutation
AT hornghueiliou antagonismofproteasomeinhibitorinducedhemeoxygenase1expressionbypink1mutation
AT mingjenlee antagonismofproteasomeinhibitorinducedhemeoxygenase1expressionbypink1mutation
AT wenmeifu antagonismofproteasomeinhibitorinducedhemeoxygenase1expressionbypink1mutation